Ascentage Pharma Group International ( ASPHF) - Stock Earnings
ASPHF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -11.3 million USD | 4.5 million USD |
| 2025Q4 | -91.6 million USD | 47.8 million USD |
| 2026Q2 | -118.6 million USD | 43.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ASPHF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -130.8 million USD | 31.4 million USD |
| 2024 | -55.5 million USD | 134.3 million USD |
| 2025 | -173.0 million USD | 79.9 million USD |
| 2026 Est. | — | — |
ASPHF
Price: $3.75
52 week price:
Earnings Per Share: -0.59 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion